Optimization of heart failure therapy: what's new from ESC Congress 2024?

The landscape of treatment for heart failure with reduced ejection fraction has seen significant advancements in recent years. With many therapies available, the challenge now is to further implement GDMT. We asked Michael Bohm (University of Saarland) what new developments have emerged at #ESCCongress 2024.
Segui Cardioinfo:
Website: bit.ly/3fzgryk
X: bit.ly/2AGPpqj
Linkedin: bit.ly/2UVRCET